Zhende Medical Statistics
Total Valuation
Zhende Medical has a market cap or net worth of CNY 5.10 billion. The enterprise value is 5.24 billion.
Market Cap | 5.10B |
Enterprise Value | 5.24B |
Important Dates
The last earnings date was Saturday, April 26, 2025.
Earnings Date | Apr 26, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Zhende Medical has 266.32 million shares outstanding. The number of shares has decreased by -0.92% in one year.
Current Share Class | n/a |
Shares Outstanding | 266.32M |
Shares Change (YoY) | -0.92% |
Shares Change (QoQ) | +3.54% |
Owned by Insiders (%) | 5.42% |
Owned by Institutions (%) | 10.91% |
Float | 105.55M |
Valuation Ratios
The trailing PE ratio is 13.20 and the forward PE ratio is 9.87.
PE Ratio | 13.20 |
Forward PE | 9.87 |
PS Ratio | 1.20 |
PB Ratio | 0.86 |
P/TBV Ratio | 1.23 |
P/FCF Ratio | n/a |
P/OCF Ratio | 11.05 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.51, with an EV/FCF ratio of -16.98.
EV / Earnings | 13.61 |
EV / Sales | 1.23 |
EV / EBITDA | 7.51 |
EV / EBIT | 12.07 |
EV / FCF | -16.98 |
Financial Position
The company has a current ratio of 2.28, with a Debt / Equity ratio of 0.09.
Current Ratio | 2.28 |
Quick Ratio | 1.50 |
Debt / Equity | 0.09 |
Debt / EBITDA | 0.79 |
Debt / FCF | -1.80 |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 6.91% and return on invested capital (ROIC) is 4.27%.
Return on Equity (ROE) | 6.91% |
Return on Assets (ROA) | 3.66% |
Return on Invested Capital (ROIC) | 4.27% |
Return on Capital Employed (ROCE) | 6.76% |
Revenue Per Employee | 634,790 |
Profits Per Employee | 57,343 |
Employee Count | 6,717 |
Asset Turnover | 0.57 |
Inventory Turnover | 3.58 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -8.42% in the last 52 weeks. The beta is 0.69, so Zhende Medical's price volatility has been lower than the market average.
Beta (5Y) | 0.69 |
52-Week Price Change | -8.42% |
50-Day Moving Average | 21.11 |
200-Day Moving Average | 21.62 |
Relative Strength Index (RSI) | 29.64 |
Average Volume (20 Days) | 2,852,435 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Zhende Medical had revenue of CNY 4.26 billion and earned 385.17 million in profits. Earnings per share was 1.45.
Revenue | 4.26B |
Gross Profit | 1.45B |
Operating Income | 434.03M |
Pretax Income | 475.46M |
Net Income | 385.17M |
EBITDA | 680.56M |
EBIT | 434.03M |
Earnings Per Share (EPS) | 1.45 |
Balance Sheet
The company has 828.39 million in cash and 554.69 million in debt, giving a net cash position of 273.70 million or 1.03 per share.
Cash & Cash Equivalents | 828.39M |
Total Debt | 554.69M |
Net Cash | 273.70M |
Net Cash Per Share | 1.03 |
Equity (Book Value) | 5.90B |
Book Value Per Share | 21.67 |
Working Capital | 1.49B |
Cash Flow
In the last 12 months, operating cash flow was 461.14 million and capital expenditures -769.69 million, giving a free cash flow of -308.55 million.
Operating Cash Flow | 461.14M |
Capital Expenditures | -769.69M |
Free Cash Flow | -308.55M |
FCF Per Share | -1.16 |
Margins
Gross margin is 34.02%, with operating and profit margins of 10.18% and 9.03%.
Gross Margin | 34.02% |
Operating Margin | 10.18% |
Pretax Margin | 11.15% |
Profit Margin | 9.03% |
EBITDA Margin | 15.96% |
EBIT Margin | 10.18% |
FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.50, which amounts to a dividend yield of 2.61%.
Dividend Per Share | 0.50 |
Dividend Yield | 2.61% |
Dividend Growth (YoY) | 66.67% |
Years of Dividend Growth | n/a |
Payout Ratio | 41.38% |
Buyback Yield | 0.92% |
Shareholder Yield | 3.53% |
Earnings Yield | 7.56% |
FCF Yield | -6.05% |
Stock Splits
The last stock split was on June 8, 2020. It was a forward split with a ratio of 1.4.
Last Split Date | Jun 8, 2020 |
Split Type | Forward |
Split Ratio | 1.4 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |